Skip to main content

Table 2 Pathological and immunohistochemical findings in duodenal GISTs, and a list of primary antibodies used in diagnosis

From: Histopathological and clinical characteristics of duodenal gastrointestinal stromal tumors as predictors of malignancy

Variable

Dilution, Source of Antibodies

Total

SkF group

non-SkF group

P value

Number

 

20

12

8

 

Tumor size – mm

 

46.5 ± 63.4

23.3 ± 8.2

81.2 ± 92.2

<0.001

Spindle type cell - no. (%)

 

13 (65%)

8 (67%)

5 (63%)

0.608

Necrosis - no. (%)

 

6 (30%)

0 (0%)

6 (75%)

<0.001

Ulceration - no. (%)

 

15 (75%)

7 (58%)

8 (100%)

0.051

Mitosis - no. per 50 HPF

 

89.6 ± 233.3

0.0 ± 0.0

224.0 ± 336.6

<0.001

Mib-1 index -%

1:200, autoclave; MBL

11.6 ± 17.4

1.8 ± 1.2

26.3 ± 20.3

<0.001

KIT - no. (%)

1:100, autoclave; Dako

20 (100%)

12 (100%)

8 (100%)

0.999

CD34 - no. (%)

1:100, autoclave; Ventana

14 (70%)

9 (75%)

5 (63%)

0.455

S-100 - no. (%)

1:1000; Dako

14 (70%)

9 (75%)

5 (63%)

0.455

α-smooth-muscle actin - no. (%)

1:200, autoclave; Dako

14 (70%)

9 (75%)

5 (63%)

0.455

Desmin - no. (%)

1:40, autoclave; Dako

11 (55%)

8 (67%)

3 (38%)

0.205

  1. Data expressed as mean ± SD, where appropriate.